Sonata Capital Group’s Amgen AMGN Stock Holding History

Sonata Capital Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-837	Closed	-$204K	–	107
2022 Q2	$204K	Hold	837	–	–	0.11%	105
2022 Q1	$202K	Sell	837 -75	-8%	-$17.2K	0.09%	116
2021 Q4	$205K	Buy	+912	New	+$192K	0.09%	119
2021 Q3	–	Sell	-912	Closed	-$222K	–	125
2021 Q2	$222K	Hold	912	–	–	0.1%	120
2021 Q1	$227K	Hold	912	–	–	0.11%	119
2020 Q4	$210K	Hold	912	–	–	0.1%	120
2020 Q3	$232K	Hold	912	–	–	0.14%	107
2020 Q2	$215K	Buy	+912	New	+$208K	0.14%	106
2020 Q1	–	Sell	-924	Closed	-$223K	–	107
2019 Q4	$223K	Buy	+924	New	+$204K	0.13%	106
2016 Q1	–	Sell	-1,262	Closed	-$205K	–	96
2015 Q4	$205K	Buy	+1,262	New	+$198K	0.18%	95

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sonata Capital Group's AMGN Position: Q3 2022 in Review

Sonata Capital Group sold out of Amgen (AMGN) in Q3 2022, closing a stake of 837 shares — an estimated $204K sold.

Sonata Capital Group first reported a position in AMGN in Q4 2015 and held it in 10 quarters. The position peaked at $232K in Q3 2020. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Sonata Capital Group reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Sonata Capital Group sold 837 Amgen shares in Q3 2022, an estimated $204K.
Sonata Capital Group first reported a position in Amgen in Q4 2015 and held it in 10 quarters.
Sonata Capital Group's Amgen position peaked at $232K in Q3 2020.
2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Sonata Capital Group's 13F filing for Q3 2022, filed 25 Oct 2022.